Protagonist Therapeutics (PTGX)
(Delayed Data from NSDQ)
$40.59 USD
+0.35 (0.87%)
Updated Aug 15, 2024 04:00 PM ET
After-Market: $40.59 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth D Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/7/24 |
---|---|
Current Quarter | -0.63 |
EPS Last Quarter | -0.50 |
Last EPS Surprise | 0.00% |
ABR | 1.00 |
Earnings ESP
|
-13.60% |
---|---|
Current Year | 2.10 |
Next Year | -1.25 |
EPS (TTM) | 2.62 |
P/E (F1) | 19.16 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 5.00M | 75.00M | 296.82M | 122.10M |
# of Estimates | 1 | 2 | 4 | 4 |
High Estimate | 5.00M | 115.00M | 369.95M | 330.00M |
Low Estimate | 5.00M | 35.00M | 259.14M | 34.50M |
Year ago Sales | 0.00M | 60.00M | 60.00M | 296.82M |
Year over Year Growth Est. | NA | 25.00% | 394.70% | -58.86% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.63 | -0.07 | 2.10 | -1.25 |
# of Estimates | 4 | 4 | 3 | 4 |
Most Recent Consensus | NA | NA | 1.44 | -1.60 |
High Estimate | -0.49 | 1.13 | 3.11 | 1.74 |
Low Estimate | -0.71 | -0.68 | 1.44 | -3.02 |
Year ago EPS | -0.58 | 0.44 | -1.39 | 2.10 |
Year over Year Growth Est. | -8.62% | -115.91% | 251.08% | -159.52% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 0 |
Up Last 60 Days | 1 | 1 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 1 | 2 | 3 |
Down Last 60 Days | 0 | 1 | 2 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.63 | -0.07 | 2.10 | -1.25 |
7 Days Ago | -0.63 | -0.07 | 2.10 | -1.25 |
30 Days Ago | -0.64 | -0.02 | 2.28 | -0.85 |
60 Days Ago | -0.64 | -0.02 | 2.28 | -0.85 |
90 Days Ago | -0.64 | -0.50 | 1.66 | -0.46 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.71 | 0.50 | 2.10 | -2.25 |
Zacks Consensus Estimate | -0.63 | -0.07 | 2.10 | -1.25 |
Earnings ESP | -13.60% | 861.54% | 0.00% | -79.74% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.50 | 3.26 | 0.44 | -0.58 | NA |
Estimate | -0.50 | 2.51 | -0.16 | -0.68 | NA |
Difference | 0.00 | 0.75 | 0.60 | 0.10 | 0.36 |
Surprise | 0.00% | 29.88% | 375.00% | 14.71% | 104.90% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more